STAT3 and hepatocellular carcinoma: IL-37 overexpression by TAMs derived from patients with human hepatocellular carcinoma (HCC) inhibits M2 polarization via regulation of the IL-6/STAT3 pathway, to suppress tumor growth in vivo [19].